A randomized, open-label, phase 2 study of enzalutamide as neoadjuvant therapy for patients undergoing prostatectomy for localized prostate cancer

Date 26 September 2015
Event European Cancer Congress 2015
Session Genitourinary Malignancies - Prostate Cancer
Topics Prostate Cancer
Presenter Montgomery, B.